Estrella Immunopharma Inc. Share Price Today, Forecast Target, Chat & Where To Buy [ESLA]

Home > Share Prices > Estrella Immunopharma Inc. share price (ESLA)

Today's Estrella Immunopharma Inc. share price is 1.2 (as of 16:00 26-Sep-2025) which is a change of 0.05 or 4.35% from the last closing price of 1.2 with 111,086 shares traded giving Estrella Immunopharma Inc. a market capitalisation of 44,478,709. The most recent daily high has been 1.23 and daily low 1.14. The Estrella Immunopharma Inc. share price 52 week high has been 1.78 and the 52 week low 0.63. Based on the most recent Estrella Immunopharma Inc. share price opening of 1.2, the current Estrella Immunopharma Inc. EPS (earnings per share) are 0.33 and the PE (price earnings ratio) is n/a.

Featured Brokers For Buying Estrella Immunopharma Inc. Shares

It currently costs 1.2 to buy one share in Estrella Immunopharma Inc. (as of 16:00 26-Sep-2025) which is a change of 0.05 or 4.35% from the last closing price of 1.15. To buy shares in Estrella Immunopharma Inc. you will need a stock trading platform like Interactive Brokers, IG or AJ Bell.

You can buy these shares in either a general investment account, stocks & shares ISA or SIPP for your pension with one of the brokers below.

We have ranked, compared and reviewed some of the best share-dealing platforms and accounts in the UK that are regulated by the Financial Conduct Authority (FCA). The main things to compare when choosing a share dealing account are the costs of buying and selling shares (trading fees) and how much it will cost to keep those shares on your account. You should also compare account types so you have the option to deal shares in a tax-efficient ISA, SIPP or for your children.

Is Estrella Immunopharma Inc. A Good Investment?

The below Estrella Immunopharma Inc. share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.

Tell us what you think:

Scroll to Top